| 【Company Research】CTGDF (601888 CH) – Lockdown in Sanya likely represents yet another entry opportunity |
| 【Company Research】Q Technology (1478 HK) – 1H22 in-line with profit warning; positive on Auto/IoT expansion |
| 【Company Research】BeiGene (BGNE US) – Strong sales continued in 2Q22 |
| 【Company Research】Baidu (BIDU US) – Auto on progress, despite slower ads recovery |
| 【Company Research】Innovent Biologics (1801 HK) – Strategic cooperation with Sanofi to strengthen presence in oncology |
| 【Company Research】Alibaba (BABA US) – China ecommerce to bottom out |
| 【Fixed Income Research】SJMHOLs: Relaxed quarantine policy and shareholder's support |
| 【Sector Research】China Software & IT Services – A mixed outlook for China cloud amid rising China-US tension |
| 【Company Research】Xiaomi (1810 HK) – 2Q22 preview: a slow quarter but mostly priced in |
| 【Company Research】Hutchmed (13 HK) – On track ramp-up of commercial products |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
